ORIC Pharmaceuticals Inc (ORIC)
5.29
+0.02
(+0.38%)
USD |
NASDAQ |
Jun 02, 16:00
5.29
0.00 (0.00%)
After-Hours: 20:00
ORIC Pharmaceuticals Research and Development Expense (Annual): 61.68M for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 61.68M |
| December 31, 2021 | 56.86M |
| December 31, 2020 | 35.92M |
| Date | Value |
|---|---|
| December 31, 2019 | 22.84M |
| December 31, 2018 | 19.03M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
19.03M
Minimum
2018
61.68M
Maximum
2022
39.27M
Average
35.92M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Twist Bioscience Corp | 120.31M |
| NovaBay Pharmaceuticals Inc | 0.174M |
| Palatin Technologies Inc | 21.33M |
| iBio Inc | 17.73M |
| Theriva Biologics Inc | 11.72M |